Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-14 | Acrivon Therapeutics, Inc. | Devroe Eric
(Chief Operating Officer) |
F | Common Stock | D | 613 | $7.92 - $7.92 | $4,854 |
2024-11-14 | Acrivon Therapeutics, Inc. | Masson Kristina
(EVP - Business Operations) |
F | Common Stock | D | 60256 | $7.92 - $7.92 | $477,226 |
2024-10-17 | Acrivon Therapeutics, Inc. | Miller Mary
(Chief Legal Officer) |
F | Common Stock | D | 558 | $7.87 - $7.87 | $4,391 |
2024-10-01 | Acrivon Therapeutics, Inc. | Miller Mary
(Chief Legal Officer) |
F | Common Stock | D | 284 | $6.98 - $6.98 | $1,982 |
2024-08-14 | Acrivon Therapeutics, Inc. | Peterson Katharine
(Chief Accounting Officer) |
F | Common Stock | D | 99 | $7.02 - $7.02 | $694 |
2024-08-14 | Acrivon Therapeutics, Inc. | Miller Mary
(Chief Legal Officer) |
F | Common Stock | D | 184 | $7.02 - $7.02 | $1,291 |
2024-08-14 | Acrivon Therapeutics, Inc. | Masson Kristina
(EVP - Business Operations) |
F | Common Stock | D | 490 | $7.02 - $7.02 | $3,439 |
2024-08-14 | Acrivon Therapeutics, Inc. | Holm-Jorgensen Ra...
(Chief Financial Officer) |
F | Common Stock | D | 368 | $7.02 - $7.02 | $2,583 |
2024-08-14 | Acrivon Therapeutics, Inc. | Gamelin Erick
(Chief Development Officer) |
F | Common Stock | D | 402 | $7.02 - $7.02 | $2,822 |
2024-08-14 | Acrivon Therapeutics, Inc. | Devroe Eric
(Chief Operating Officer) |
F | Common Stock | D | 613 | $7.02 - $7.02 | $4,303 |
2024-08-14 | Acrivon Therapeutics, Inc. | Blume-Jensen Peter
(President and CEO) |
F | Common Stock | D | 59765 | $7.02 - $7.02 | $419,550 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |